Nevro Corp. (NVRO) Financials
NVRO Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 635.7 million | 330.3 million |
| 2023-09-30 | 561.6 million | 275.9 million |
| 2023-06-30 | 569.5 million | 274.8 million |
| 2023-03-31 | 574.4 million | 273.2 million |
NVRO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | -16.6 million | 13.6 million |
| 2023-09-30 | -8.0 million | 13.5 million |
| 2023-06-30 | -16.7 million | 16.2 million |
| 2023-03-31 | -31.9 million | 13.6 million |
NVRO Net Income
No data available :(
NVRO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 322.7 million | - | 4.6 million |
| 2023-09-30 | 320.3 million | - | 6.1 million |
| 2023-06-30 | 329.9 million | - | 7.6 million |
| 2023-03-31 | 341.8 million | 187.2 million | 8.9 million |
NVRO Shares Outstanding
NVRO Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 1.9 million | 12.4 million | 80.6 million | - |
| 2023-09-30 | 1.9 million | 13.9 million | 81.2 million | - |
| 2023-06-30 | 2.2 million | 13.3 million | 86.8 million | - |
| 2023-03-31 | 2.6 million | 14.8 million | 86.2 million | - |
NVRO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 116.2 million | 37.7 million |
| 2023-09-30 | 103.9 million | 34.3 million |
| 2023-06-30 | 108.8 million | 34.4 million |
| 2023-03-31 | 96.3 million | 31.7 million |
NVRO
Price: $11.32
52 week price:
Earnings Per Share: -2.56 USD
P/E Ratio: -6.02
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Volume: 496000
Ebitda: -2.7 millionMarket Capitalization: 482.3 million